# Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis

> **NCT04714411** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 42 (actual)

## Conditions studied

- Diabetic Foot Infection

## Interventions

- **DRUG:** Omadacycline

## Key facts

- **NCT ID:** NCT04714411
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-05
- **Primary completion:** 2025-07-14
- **Final completion:** 2025-07-14
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04714411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04714411, "Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04714411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*